ApoA2 isoforms |
Apolipoprotein A2 |
Component of high-density lipoprotein particles |
[30,31] |
CA125 |
Carcinoma antigen 125, Mucin 16 |
O-glycosylated protein that functions in forming a protective mucous barrier |
[32,33]
|
CA19–9 |
Cancer antigen 19–9, carbohydrate antigen sialyl Lewis a |
A glycosphingolipid that functions in embryogenesis that is secondarily absorbed to red blood cells |
[31,34–36] |
CEA |
Carcinoembryonic antigen, carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 |
Cell surface glycoprotein that functions in cell adhesion |
[19,33,35,37,38] |
CPA1 |
Carboxypeptidase A1 |
A zinc metalloprotease that cleaves select dietary proteins |
[34] |
DUPAN-2 |
Duke pancreatic monoclonal antigen type 2 |
A precursor of CA 19–9 |
[39] |
GDF15/MIC-1 |
Growth differentiation factor 15 |
A secreted ligand in the transforming growth factor-beta superfamily of proteins |
[40,41] |
LRG1 |
Leucine rich alpha-2-glycoprotein 1 |
Functions in protein-protein interactions, cell adhesion, and signal transduction |
[42,43] |
MUC5AC |
Mucin 5AC |
Protects mucosal surfaces, and functions in phosphatidylinositol-mediated signaling |
[44] |
SPP1 |
Osteopontin |
Attachment of osteoclasts to mineralized bone matrix (hydroxyapatite) |
[33,38,45,46] |
THBS2 |
Thrombospondin-2 |
A glycoprotein that mediates cell-cell and cell-matrix interactions |
[47–49] |
TIMP1 |
Tissue inhibitor of metalloproteinases 1 |
As the name suggests, inhibits matrix metalloproteinases |
[23,50] |